Showing 1 - 7 of 7
This paper explores the massive strides that were made in response to the COVID-19 pandemic by national drug regulatory agencies (NRAs) in order to achieve what ultimately became the fastest incidence in human history of the development, testing, approval, manufacture, and distribution of a new...
Persistent link: https://www.econbiz.de/10014077111
The global health crisis that came to be known as the COVID-19 pandemic and started to sweep across the world in early 2020 revealed many vulnerabilities in the economic, social, and political fabric underpinning what much of the world had come to accept as normal. In ways that we are still...
Persistent link: https://www.econbiz.de/10013417628
Timely and equitable access to vaccines and other health technologies is vital in effectively responding to pandemics and treating other communicable diseases. This paper shows how countries might overcome real or purported intellectual property (IP) barriers to regional COVID-19 vaccine...
Persistent link: https://www.econbiz.de/10013479631
Persistent link: https://www.econbiz.de/10003118558
Persistent link: https://www.econbiz.de/10003065664
Understanding the development effects of official aid is crucial to building a better bridge between research and policy. This paper reviews the current evidence regarding the impact of aid on growth and poverty reduction, and develops a new narrative. In the light of this narrative, the paper...
Persistent link: https://www.econbiz.de/10013044069
Understanding the development effects of official aid is crucial to building a better bridge between research and policy. This paper reviews the current evidence regarding the impact of aid on growth and poverty reduction, and develops a new narrative. In the light of this narrative, the paper...
Persistent link: https://www.econbiz.de/10013044160